Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04726410 · ClinicalTrials.gov registry record · Phase 2
Cold-stored Platelet Early Intervention in TBI
A Phase 2 study, sponsored by Jason Sperry.
- Completed
- Registry status
- Phase 2
- Development phase
- 100
- Enrollment target
NCT04726410 is a Phase 2 study that has completed, run by Jason Sperry. The registered enrollment target is 100 participants.
The verdict
NCT04726410, a Phase 2 study, has completed, sponsored by Jason Sperry.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 100 participants
- Enrollment target
Study Summary
The Cold Stored Platelet Early Intervention in Traumatic Brain Injury (CriSP-TBI) trial is a proposed 3 year, open label, single center, randomized trial designed to determine the feasibility, efficacy, and safety of urgent release cold stored platelets (CSP) in patients with TBI requiring platelet transfusion. Patients will be randomized to receive either standard care or early infusion of urgent release cold stored platelets (CSP). The proposed pilot study will enroll at the University of Pittsburgh and will enroll approximately 100 patients. The primary outcome for the pilot trial is feasibility, with principal secondary clinical outcome of 6-month Extended Glasgow Outcome Scale (GOS-E).
Interventions
- BIOLOGICAL Cold Stored Platelets
- BIOLOGICAL Standard Care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2022-03-21 |
| Est. Completion | 2024-05-13 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04726410
The ClinicalTrials.gov registry entry for NCT04726410 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Jason Sperry, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Cold Stored Platelets is the first listed.
NCT04726410 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04726410 about?
NCT04726410 is a clinical study titled "Cold-stored Platelet Early Intervention in TBI". The Cold Stored Platelet Early Intervention in Traumatic Brain Injury (CriSP-TBI) trial is a proposed 3 year, open label, single center, randomized trial designed to determine the feasibility, efficacy, and safety of urgent release cold stored platelets (CSP) in patients with TBI requiring platelet ...
What is the current status of trial NCT04726410?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 100 participants. The study started on 2022-03-21. Estimated completion is 2024-05-13.
What interventions are being tested in trial NCT04726410?
The interventions under investigation include: Cold Stored Platelets (BIOLOGICAL), Standard Care (BIOLOGICAL).
Who is sponsoring clinical trial NCT04726410?
This trial is sponsored by Jason Sperry, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.